Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$703.64B | 35.9x | 1.45 | US$87.82 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.9% Upside | Upgrade to Pro+ | |
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$44.55B | 18.1x | 0.69 | US$67.72 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.9% Upside | Upgrade to Pro+ | |
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$37.64B | 19.7x | -4.2 | US$77.13 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.7% Upside | Upgrade to Pro+ | |
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$37.40B | 52.2x | -0.97 | US$14.49 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$37.40B | 52.2x | -0.97 | US$14.25 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$34.57B | 52.2x | -0.6 | US$96.62 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$34.35B | 18.3x | -6.85 | US$37.53 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$34.35B | 18.3x | -6.85 | US$37.46 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$32.68B | 20.1x | -2.96 | US$4.87 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$32.68B | 20.1x | -2.96 | US$14.75 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.7% Downside | Upgrade to Pro+ | |
Aeon ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$22.70B | 312.8x | -4.09 | US$26.31 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coles Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$15.90B | 22.9x | 3.97 | US$10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$14.67B | 30.8x | US$63.63 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | ||
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$14.25B | 26.5x | 2.51 | US$381.68 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.94B | 20x | -1.59 | US$44.27 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.39B | 18.2x | 0.5 | US$16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.07B | 34.8x | 0.71 | US$132.75 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.1% Upside | Upgrade to Pro+ | |
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$12.28B | 11.7x | -0.49 | US$21.15 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.8% Upside | Upgrade to Pro+ | |
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$11.77B | 30.5x | 4.38 | US$63.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$11.75B | 29.7x | -3.31 | US$74.92 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.9% Upside | Upgrade to Pro+ | |
Walgreens Boots | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.75B | -1.1x | 0 | US$11.28 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.5% Upside | Upgrade to Pro+ | |
Luckin Coffee | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.57B | 23.3x | 8.82 | US$28.04 | -6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.5% Upside | Upgrade to Pro+ | |
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.51B | 14.4x | 0.62 | US$9.63 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8% Upside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.51B | 14.4x | 0.64 | US$4.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.34B | 12.4x | -0.22 | US$2.84 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | |
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.20B | 20x | -0.83 | US$10.44 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sendas Distribuidora | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.18B | 75.9x | 1.45 | US$6.25 | 7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.8% Upside | Upgrade to Pro+ | |
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.17B | 22.5x | 2.49 | US$14.79 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$7.75B | 104.2x | -1.27 | US$13.50 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.4% Downside | Upgrade to Pro+ | |
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$5.20B | 24.4x | 1.57 | US$3.20 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Etablissementen Franz Colruyt ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$5.17B | 13.8x | -0.21 | US$10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Axfood ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$5.09B | 22.5x | -3.4 | US$25.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clicks Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.46B | 28.7x | 2 | US$37.03 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DFI Retail Holdings DRC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.87B | 23.8x | 0.07 | US$10.91 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BBB Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.80B | 226.3x | 1.62 | US$24.10 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.4% Upside | Upgrade to Pro+ | |
Sun Art Retail ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.33B | -15.4x | 0.03 | US$2.68 | 16.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Weis Markets | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.23B | 20x | 3.38 | US$82.56 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Chefs Warehouse | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.13B | 35.9x | 0.81 | US$52.88 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.6% Upside | Upgrade to Pro+ | |
Hellofresh | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.74B | -14.1x | 0.04 | US$9.61 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Thumb Industries | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.65B | 22.5x | 0.23 | US$6.70 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
United Natural Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.54B | -16.4x | 1.12 | US$25.83 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Vital Farms | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.42B | 25.5x | 0.27 | US$32.04 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.9% Upside | Upgrade to Pro+ | |
SPAR ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.34B | 69.2x | -1.21 | US$6.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grocery Outlet | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.31B | 33.1x | -0.65 | US$13.46 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.9% Upside | Upgrade to Pro+ | |
Ingles | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.22B | 15.5x | -0.26 | US$63.99 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guardian Pharmacy Services | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.17B | -13.8x | US$18.37 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.9% Upside | Upgrade to Pro+ | ||
Pick N Pay ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.13B | -4.3x | 0 | US$6.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Robinsons Retail Holdings Inc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$953.68M | 5.4x | 0.03 | US$5.89 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SpartanNash Co | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$689.14M | 2,240x | -23.01 | US$20.39 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
Village Super Market | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$503.90M | 9.1x | 2.51 | US$33.93 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |